"LS-variant anti-CCR5 monoclonal antibody provides
Post# of 158026

protection against intrarectal SHIV acquisition in rhesus macaques""
Recent presentation:
Poster
https://www.google.com/url?sa=t&source=we...lq2EnIJYLj
"These data demonstrate the ability of LS-variant Leronlimab to provide long-term protection against intrarectal SHIV acquisition and support development of long-acting CCR5 blockade for HIV PrEP.

